Services for the Preclinical Development of Therapeutic Agents
$481,746N01FY2022AINIH
Sri International, Menlo Park CA
Investigators
Abstract
The Services for the Preclinical Development of Therapeutic Agents contract offers a collection of preclinical services to support the development of promising therapeutic candidates, including those for lead identification and development, chemistry and manufacturing, in vitro microbiological services; in vitro and in vivo preclinical safety, toxicology and biokinetics; and pre-clinical development planning and evaluation.
View original record on NIH RePORTER →